Friday, September 30, 2016

Blood Cancer Journal - Table of Contents alert Volume 6 September 2016

If you are unable to see the message below, click here to view.
Blood Cancer Journal

TABLE OF CONTENTS

Volume 6, September 2016

In this issue
Original Articles
Letters to the Editor
Corrigendum
Sign up for e-alerts Sign up for e-alerts
Web feed
Advertisement
Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders.

Explore the benefits of submitting your next research article.

Original Articles

Top

Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-up

N Biran, S Jacobus, D H Vesole, N S Callander, R Fonseca, M E Williams, R Abonour, M S Katz, S V Rajkumar, P R Greipp and D S Siegel

Blood Cancer J 2016 6: e466; 10.1038/bcj.2016.68

Abstract | Full Text

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma

N Bolli, Y Li, V Sathiaseelan, K Raine, D Jones, P Ganly, F Cocito, G Bignell, M A Chapman, A S Sperling, K C Anderson, H Avet-Loiseau, S Minvielle, P J Campbell and N C Munshi

Blood Cancer J 2016 6: e467; 10.1038/bcj.2016.72

Abstract | Full Text

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

N Gökbuget, M Kelsh, V Chia, A Advani, R Bassan, H Dombret, M Doubek, A K Fielding, S Giebel, V Haddad, D Hoelzer, C Holland, N Ifrah, A Katz, T Maniar, G Martinelli, M Morgades, S O'Brien, J-M Ribera, J M Rowe, A Stein, M Topp, M Wadleigh and H Kantarjian

Blood Cancer J 2016 6: e473; 10.1038/bcj.2016.84

Abstract | Full Text

MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients

S Harrach, C Schmidt-Lauber, T Pap, H Pavenstädt, E Schlatter, E Schmidt, W E Berdel, U Schulze, B Edemir, S Jeromin, T Haferlach, G Ciarimboli and J Bertrand

Blood Cancer J 2016 6: e470; 10.1038/bcj.2016.79

Abstract | Full Text

ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)

Y Jiang, H-C Chen, X Su, P A Thompson, X Liu, K-A Do, W Wierda, M J Keating and W Plunkett

Blood Cancer J 2016 6: e465; 10.1038/bcj.2016.69

Abstract | Full Text

Novel function of FAXDC2 in megakaryopoiesis

Q Jin, Y Ren, M Wang, P K Suraneni, D Li, J D Crispino, J Fan and Z Huang

Blood Cancer J 2016 6: e478; 10.1038/bcj.2016.87

Abstract | Full Text

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome

D Ronchetti, M Manzoni, L Agnelli, C Vinci, S Fabris, G Cutrona, S Matis, M Colombo, S Galletti, E Taiana, A G Recchia, S Bossio, M Gentile, C Musolino, F Di Raimondo, A Grilli, S Bicciato, A Cortelezzi, P Tassone, F Morabito, M Ferrarini and A Neri

Blood Cancer J 2016 6: e468; 10.1038/bcj.2016.77

Abstract | Full Text

Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors

G Venton, M Pérez-Alea, C Baier, G Fournet, G Quash, Y Labiad, G Martin, F Sanderson, P Poullin, P Suchon, L Farnault, C Nguyen, C Brunet, I Ceylan and R T Costello

Blood Cancer J 2016 6: e469; 10.1038/bcj.2016.78

Abstract | Full Text

Letters to the Editor

Top

Amyloid cast tubulopathy: a unique form of immunoglobulin-induced renal disease

I-A Iliuta, A P Garneau, E Latulippe and P Isenring

Blood Cancer J 2016 6: e474; 10.1038/bcj.2016.74

Full Text

Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era

A Kawajiri, D Maruyama, A M Maeshima, J Nomoto, S Makita, H Kitahara, K-i Miyamoto, S Fukuhara, T Suzuki, W Munakata, K Tajima, J Itami, H Taniguchi, Y Kobayashi and K Tobinai

Blood Cancer J 2016 6: e477; 10.1038/bcj.2016.88

Full Text

Bone marrow stromal cells show distinct gene expression patterns depending on symptomatically involved organs in multiple myeloma

S Y Kim, K Im, S N Park, B Oh, J-A Kim, S M Hwang, M Kim, S-S Yoon and D S Lee

Blood Cancer J 2016 6: e476; 10.1038/bcj.2016.86

Full Text

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance

M M Patnaik, M F Zahid, T L Lasho, C Finke, R L Ketterling, N Gangat, K D Robertson, C A Hanson and A Tefferi

Blood Cancer J 2016 6: e472; 10.1038/bcj.2016.82

Full Text

Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia

J Vargova, K Vargova, N Dusilkova, V Kulvait, V Pospisil, J Zavadil, M Trneny, P Klener and T Stopka

Blood Cancer J 2016 6: e475; 10.1038/bcj.2016.80

Full Text

Corrigendum

Top

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Y Jethava, A Mitchell, M Zangari, S Waheed, C Schinke, S Thanendrarajan, J Sawyer, D Alapat, E Tian, C Stein, R Khan, C J Heuck, N Petty, D Avery, D Steward, R Smith, C Bailey, J Epstein, S Yaccoby, A Hoering, J Crowley, G Morgan, B Barlogie and F van Rhee

Blood Cancer J 2016 6: e471; 10.1038/bcj.2016.85

Full Text

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: